Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mascia Albizzi"'
Autor:
D. Bruttomesso, C. Irace, P. Pozzilli, Roberto Anichini, Alice Magiar, Cristiana Maria Baggiore, Olga Disoteo, Antonella Porcu, Enzo Bonora, Maddalena Trombetta, Daniela Bruttomesso, Federico Boscari, Mario Carrano, Maria Gisella Cavallo, Marco Giorgio Baroni, Alberto Di Carlo, Ilaria Casadidio, Maurizio Di Mauro, Angelo Foglia, Anna De Simone, Lucia Frittitta, Gabriella Garrapa, Bruno Giorda, Elisa Nada Chieri, Giuseppina Guarino, Sandro Gentile, Concetta Irace, Serena Catalano, Davide Lauro, Davide Maggi, Eleonora Ambrosett, Marianna Maranghi, Daniela Pergolini, Maria Letizia Petroni, Francesca Marchignoli, Emanuela Orsi, Alessia Gaglio, Piermarco Piatti, Lucilla Monti, Paolo Pozzilli, Silvia Pieralice, Filippo Privitera, Roberto Trevisan, Mascia Albizzi, Raffaella Buzzetti, Angela Carlone, Dario Pitocco, Linda Tartaglione
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67670df3c84adfd7e3673206bca23aa1
https://hdl.handle.net/20.500.11769/551485
https://hdl.handle.net/20.500.11769/551485
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Silvia Galliani, Giorgia Cavalli, Cristiana Scaranna, Anna Maria Corsi, Giuseppe Lepore, Mascia Albizzi, Rosalia Bellante, G. Mangili, Alessandro Roberto Dodesini, Elena Ciriello, Roberto Trevisan
Publikováno v:
Journal of Diabetes. 12:860-861
Autor:
Roberto Attanasio, Renato Cozzi, M. Montini, Giovanni Lasio, Paola Doneda, Mascia Albizzi, Liana Cortesi, Giorgio Pagani, Sandro Lodrini
Publikováno v:
The Journal of clinical endocrinology and metabolism. 91(4)
Neurosurgery is regarded as the first-line treatment of acromegaly. Because of its low cure rate in macro and invasive adenoma, the role of primary medical treatment is debated.Our objective was to evaluate primary pharmacological treatment in acrome
Autor:
Giovanni Lasio, G Pagani, M. Barausse, Mascia Albizzi, Roberto Attanasio, D. Dallabonzana, Renato Cozzi, Alberto M Pedroncelli, Sandro Lodrini, M. Montini
Publikováno v:
The Journal of clinical endocrinology and metabolism. 88(7)
The effects of a very prolonged treatment with octreotide (OC)-long-acting repeatable (LAR) were retrospectively evaluated in 110 patients with acromegaly, showing a GH/IGF-I decrease of at least 20% vs. baseline after a short-term (6-month) OC-LAR c